China SXT Pharmaceuticals (SXTC) Current Deferred Tax Assets (2020)
China SXT Pharmaceuticals (SXTC) posted Current Deferred Tax Assets of $50000.0 for Q1 2020.
Analysis
China SXT Pharmaceuticals (SXTC) Current Deferred Tax Assets (2020) Analysis & Trends
China SXT Pharmaceuticals has reported Current Deferred Tax Assets for 1 years, with the latest figure at $50000.0 in Q1 2020.
- On a quarterly basis, Current Deferred Tax Assets changed N/A year-over-year to $50000.0 in Q1 2020; TTM through Mar 2020 was $50000.0, a N/A change from a year earlier, with the FY2020 full-year figure at $50000.0, changed N/A from the prior year.
- Current Deferred Tax Assets was $50000.0 for Q1 2020 at China SXT Pharmaceuticals.
- The five-year high for Current Deferred Tax Assets was $50000.0 in Q1 2020, with the low at $50000.0 in Q1 2020.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 645.47 Bn | 624.71 Bn | 17.26 Bn |
| 2 | AbbVie | 439.99 Bn | 433.42 Bn | 12.70 Bn |
| 3 | Merck | 365.45 Bn | 358.31 Bn | 12.21 Bn |
| 4 | Novartis Ag | 266.57 Bn | 258.88 Bn | 11.24 Bn |
| 5 | Pfizer | 159.03 Bn | 147.33 Bn | 10.94 Bn |
| 6 | Sanofi | 52.43 Bn | 45.05 Bn | 10.79 Bn |
| 7 | Revolution Medicines | 44.23 Bn | 44.23 Bn | - |
| 8 | Incyte | 25.32 Bn | 20.79 Bn | 1.57 Bn |
| 9 | United Therapeutics | 21.44 Bn | 18.77 Bn | 683.80 Mn |
| 10 | China SXT Pharmaceuticals | 19,200.96 | -28.16 Mn | - |